First-In-Human Study of ChAdOx1-HBV & MVA-HBV Vaccines (VTP-300) for Chronic HBV

NCT04778904 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B

Interventions

BIOLOGICAL: ChAdOx1-HBV
BIOLOGICAL: MVA-HBV
BIOLOGICAL: Nivolumab

Sponsor

Barinthus Biotherapeutics